SB 1867

relating to the addition of certain substances to Penalty Group 2 of
the Texas Controlled Substances Act.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1.  Section 481.103(a), Health and Safety Code, is
(a)  Penalty Group 2 consists of:
(1)  any quantity of the following hallucinogenic
substances, their salts, isomers, and salts of isomers, unless
specifically excepted, if the existence of these salts, isomers,
and salts of isomers is possible within the specific chemical
5-(2-aminopropyl)benzofuran (5-APB);
6-(2-aminopropyl)benzofuran (6-APB);
5-(2-aminopropyl)-2,3-dihydrobenzofuran
6-(2-aminopropyl)-2,3-dihydrobenzofuran
5-(2-aminopropyl)indole (5-IT,5-API);
6-(2-aminopropyl)indole (6-IT,6-API);
1-(benzofuran-5-yl)-N-methylpropan-2-amine
1-(benzofuran-6-yl)-N-methylpropan-2-amine
Benzothiophenylcyclohexylpiperidine (BTCP);
8-bromo-alpha-methyl-benzo[1,2-b:4,5-b']difuran-
4-ethanamine (trade or other name: Bromo-DragonFLY);
Desoxypipradrol (2-benzhydrylpiperidine);
2, 5-dimethoxyamphetamine (some trade or other
names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA);
Diphenylprolinol (diphenyl(pyrrolidin-2-yl)
Dronabinol (synthetic) in sesame oil and
encapsulated in a soft gelatin capsule in a U.S. Food and Drug
Administration approved drug product (some trade or other names for
Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9-
trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9-
(trans)- tetrahydrocannabinol);
Ethylamine Analog of Phencyclidine (some trade or
other names: N-ethyl-1-phenylcyclohexylamine, (1-
phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine,
2-ethylamino-2-(3-methoxyphenyl)cyclohexanone
(trade or other name: methoxetamine);
Ibogaine (some trade or other names: 7-Ethyl-6,
6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-
pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.);
5-methoxy-3, 4-methylenedioxy amphetamine;
4-methoxyamphetamine (some trade or other
names: 4-methoxy-alpha-methylphenethylamine;
4-methoxymethamphetamine (PMMA);
2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone
(some trade and other names: 2-MeO-ketamine; methoxyketamine);
1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP,
4-methyl-2, 5-dimethoxyamphetamine (some trade
and other names: 4-methyl-2, 5-dimethoxy-alpha-
methylphenethylamine; "DOM"; "STP");
3,4-methylenedioxy methamphetamine (MDMA, MDM);
3,4-methylenedioxy amphetamine;
3,4-methylenedioxy N-ethylamphetamine (Also
5,6-methylenedioxy-2-aminoindane (MDAI);
Nabilone (Another name for nabilone: (+)-trans-
3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6,
6-dimethyl-9H-dibenzo[b,d] pyran-9-one;
N-benzylpiperazine (some trade or other
names: BZP; 1-benzylpiperazine);
N-hydroxy-3,4-methylenedioxyamphetamine (Also
N-methyl-3-piperidyl benzilate;
Parahexyl (some trade or other names: 3-Hexyl-1-
hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d]
1-Piperidinocyclohexanecarbonitrile (PCC);
Pyrrolidine Analog of Phencyclidine (some trade
or other names:  1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP);
Tetrahydrocannabinols, other than marihuana, and
synthetic equivalents of the substances contained in the plant, or
in the resinous extractives of Cannabis, or synthetic substances,
derivatives, and their isomers with similar chemical structure and
pharmacological activity such as:
delta-1 cis or trans tetrahydrocannabinol,
delta-6 cis or trans tetrahydrocannabinol,
tetrahydrocannabinol, and its optical isomers; [or]
delta-5, cis or trans tetrahydrocannabinol,
delta-6a, cis or trans tetrahydrocannabinol,
delta-7, cis or trans tetrahydrocannabinol,
delta-7a, cis or trans tetrahydrocannabinol,
delta-8, cis or trans tetrahydrocannabinol,
delta-9, cis or trans tetrahydrocannabinol,
delta-10, cis or trans tetrahydrocannabinol,
tetrahydrocannabinol, and their optical isomers;
delta-11, cis or trans tetrahydrocannabinol,
delta-11-Hydroxy-tetrahydrocannabinol;
1-pentyl-3-(1-naphthoyl) indole (JWH-018);
1-butyl-3-(1-naphthoyl) indole (JWH-073);
1-pentyl-3-(4-methoxynaphthoyl) indole
1-pentyl-3-(2-methoxynaphthoyl) indole
1-pentyl-3-(4-chloronaphthoyl) indole
5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-
hydroxycyclohexyl]-phenol (CP-47,497);
(6aR,10aR)-9-(hydroxymethyl)-6,6-
dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo
(6a,10a)-9-(hydroxymethyl)-6,6-
dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H-benzo
tetrahydrocannabivarins, including delta-8
metabolites of tetrahydrocannabinol,
including 11-hydroxy-tetrahydrocannabinol,
3-hydroxy-tetrahydrocannabinol, and
7-hydroxy-tetrahydrocannabinol;
hexahydrocannabiphorol-o-ester;
hydrogenated forms of tetrahydrocannabinol,
including hexahydrocannabinol, hexahydrocannabiphorol, and
hydrogenated forms of hexahydrocannabinol
(HHC), including 8-hydroxyhexahydrocannabinol and
ester forms of tetrahydrocannabinol,
including delta-8 THC-O-acetate, delta-9 THC-O-acetate, and
tetrahydrocannabinols with alkyl chain of
four or more carbon atoms, including tetrahydrocannabiphorols
(THCP), tetrahydrocannabioctyls, tetrahydrocannabihexols (THCH),
tetrahydrocannabidiol (THC-JD), and tetrahydrocannabutols;
tetrahydrocannabinol acetate (THC-O);
tetrahydrocannabinol methyl ester;
N-(1-Amino-1-methyl-ethyl)-5-fluoropen
tyl-1-naphthalen-2-yl-1H-indole-3-carboxamide (XRL-11 &15);
N-(1-Amino-1-methyl-ethyl)-5-fluoropen
tyl-1-naphthalen-2-yl-1H-indole-3-carboxamide (UR-144);
N-(1-Amino-1-methyl-ethyl)-5-fluoropen
tyl-1-naphthalen-2-yl-1H-indole-3-carboxamide (FUB-144);
N-(1-Amino-1-methyl-ethyl)-5-fluoropen
tyl-1-naphthalen-2-yl-1H-indole-3-carboxamide (AMB-FUBINACA);
(3-[(1R,4R)-Isopropyl-2-methyl-1,3-benzo
dioxol-5-yl]-N-(2,4-dimethyl-3-methylbenzoyl)-N-methyl-1,2,3,4-
tetrahydroisoquinolin-6-amine) (THJ-220);
(3-[(1R,4R)-Isopropyl-2-methyl-1,3-benzo
dioxol-5-yl]-N-(2,4-dimethyl-3-methylbenzoyl)-N-methyl-1,2,3,4-
tetrahydroisoquinolin-6-amine) (RCS-4);
compounds of these structures, regardless of
numerical designation of atomic positions, since nomenclature of
these substances is not internationally standardized;
Thiophene Analog of Phencyclidine (some trade or
other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl
Analog of Phencyclidine; TPCP, TCP);
1-pyrrolidine (some trade or other name: TCPy);
1-(3-trifluoromethylphenyl)piperazine (trade or
(2)  Phenylacetone (some trade or other
names:  Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl
(3)  unless specifically excepted or unless listed in
another Penalty Group, a material, compound, mixture, or
preparation that contains any quantity of the following substances
having a potential for abuse associated with a depressant or
stimulant effect on the central nervous system:
Aminorex (some trade or other names: aminoxaphen;
2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5-
Amphetamine, its salts, optical isomers, and
Cathinone (some trade or other names: 2-amino-1-
phenyl-1-propanone, alpha-aminopropiophenone, 2-
Lisdexamfetamine, including its salts, isomers,
Methcathinone (some trade or other names: 2-
methylamino-propiophenone; alpha-(methylamino)propriophenone;
2-(methylamino)-1-phenylpropan-1-one; alpha-N-
methylaminopropriophenone; monomethylpropion; ephedrone, N-
methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR
N-Ethylamphetamine, its salts, optical isomers,
and salts of optical isomers; and
N,N-dimethylamphetamine (some trade or other
names: N,N,alpha-trimethylbenzeneethanamine;
N,N,alpha-trimethylphenethylamine), its salts, optical isomers,
(4)  any compound structurally derived from
2-aminopropanal by substitution at the 1-position with any
monocyclic or fused-polycyclic ring system, including:
(A)  compounds further modified by:
(i)  substitution in the ring system to any
extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or
halide substituents), whether or not further substituted in the
ring system by other substituents;
(ii)  substitution at the 3-position with an
(iii)  substitution at the 2-amino nitrogen
atom with alkyl, benzyl, dialkyl, or methoxybenzyl groups, or
inclusion of the 2-amino nitrogen atom in a cyclic structure; and
(B)  by example, compounds such as:
4-Methylmethcathinone (Also known as
3,4-Dimethylmethcathinone (Also known as
3-Fluoromethcathinone (Also known as 3-FMC);
4-Fluoromethcathinone (Also known as
3,4-Methylenedioxy-N-methylcathinone (Also
3,4-Methylenedioxypyrovalerone (Also known
alpha-Pyrrolidinopentiophenone (Also known
Naphthylpyrovalerone (Also known as
alpha-Methylamino-valerophenone (Also known
beta-Keto-N-methylbenzodioxolylpropylamine
beta-Keto-N-methylbenzodioxolylpentanamine
beta-Keto-Ethylbenzodioxolylbutanamine
3,4-methylenedioxy-N-ethylcathinone (Also
(5)  any compound structurally derived from tryptamine
(3-(2-aminoethyl)indole) or a ring-hydroxy tryptamine:
(A)  by modification in any of the following ways:
(i)  by substitution at the amine nitrogen
atom of the sidechain to any extent with alkyl or alkenyl groups or
by inclusion of the amine nitrogen atom of the side chain (and no
other atoms of the side chain) in a cyclic structure;
(ii)  by substitution at the carbon atom
adjacent to the nitrogen atom of the side chain (alpha-position)
with an alkyl or alkenyl group;
(iii)  by substitution in the 6-membered
ring to any extent with alkyl, alkoxy, haloalkyl, thioaklyl,
alkylenedioxy, or halide substituents; or
(iv)  by substitution at the 2-position of
the tryptamine ring system with an alkyl substituent; and
(i)  ethers and esters of the controlled
substances listed in this subdivision; and
(ii)  by example, compounds such as:
Bufotenine (some trade and other names:
3-(beta-Dimethylaminoethyl)-5-hydroxyindole;
3-(2-dimethylaminoethyl)- 5- indolol; N, N-dimethylserotonin;
5-hydroxy-N, N- dimethyltryptamine; mappine);
Diethyltryptamine (some trade and
other names: N, N-Diethyltryptamine, DET);
Dimethyltryptamine (trade or other
5-methoxy-N, N-diisopropyltryptamine
O-Acetylpsilocin (Trade or other name:
(6)  2,5-Dimethoxyphenethylamine and any compound
structurally derived from 2,5-Dimethoxyphenethylamine by
substitution at the 4-position of the phenyl ring to any extent
(including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide
substituents), including, by example, compounds such as:
4-Bromo-2,5-dimethoxyphenethylamine (trade or
4-Chloro-2,5-dimethoxyphenethylamine (trade or
2,5-Dimethoxy-4-methylphenethylamine (trade or
4-Ethyl-2,5-dimethoxyphenethylamine (trade or
4-Iodo-2,5-dimethoxyphenethylamine (trade or
2,5-Dimethoxy-4-nitrophenethylamine (trade or
2,5-Dimethoxy-4-(n)-propylphenethylamine (trade
4-Ethylthio-2,5-dimethoxyphenethylamine (trade
4-Isopropylthio-2,5-dimethoxyphenethylamine
(trade or other name: 2C-T-4); and
2,5-Dimethoxy-4-(n)-propylthiophenethylamine
(trade or other name: 2C-T-7); and
(7)  2,5-Dimethoxyamphetamine and any compound
structurally derived from 2,5-Dimethoxyamphetamine by substitution
at the 4-position of the phenyl ring to any extent (including alkyl,
alkoxy, alkylenedioxy, haloalkyl, or halide substituents),
including, by example, compounds such as:
4-Ethylthio-2,5-dimethoxyamphetamine (trade or
4-Isopropylthio-2,5-dimethoxyamphetamine (trade
4-Bromo-2,5-dimethoxyamphetamine (trade or other
4-Chloro-2,5-dimethoxyamphetamine (trade or
2,5-Dimethoxy-4-ethylamphetamine (trade or other
4-Iodo-2,5-dimethoxyamphetamine (trade or other
2,5-Dimethoxy-4-methylamphetamine (trade or
2,5-Dimethoxy-4-nitroamphetamine (trade or other
4-Isopropyl-2,5-dimethoxyamphetamine (trade or
2,5-Dimethoxy-4-(n)-propylamphetamine (trade or
SECTION 2.  The change in law made by this Act applies only
to an offense committed on or after the effective date of this
Act.  An offense committed before the effective date of this Act is
governed by the law in effect on the date the offense was committed,
and the former law is continued in effect for that purpose.  For
purposes of this section, an offense was committed before the
effective date of this Act if any element of the offense occurred
SECTION 3.  This Act takes effect September 1, 2025.